Drug Database
AG

AGP-103 (Esapent / Eskim / EPA + DHA)

✓ Approved

Pronova BioPharma ASA · 治疗药物

什么是 AGP-103?

AGP-103 是一种治疗药物,由Pronova BioPharma ASA研发。该药已获批,用于治疗相关适应症。

药物档案

商品名Esapent, Eskim, EPA + DHA
公司Pronova BioPharma ASA
状态Approved

治疗适应症

AGP-103 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersHypertriglyceridaemia✓ Approved

相关研究文献

PubMedFrontiers in surgery2026-11-17

Early (<3 months) versus late (≥3 months) periprosthetic femoral fractures after hip arthroplasty: fracture characteristics and treatment patterns.

Qiu Changmao C, Zhang Kai K, Wang Qikui Q, Zhang Ruipeng R et al.

To describe and compare injury context, fracture morphology, bone stock, and treatment patterns between periprosthetic femoral fractures (PFFs) occurring <3 months and ≥3 months after index hip arthroplasty using a prespecified operational timing threshold. We retrospectively reviewed consecutive patients hospitalized for their first documented PFF episode after total hip arthroplasty or hemiarthroplasty at a tertiary orthopedic referral hospital from January 2021 through December 2025. Early PFF was defined as <3 months and late PFF as ≥3 months using a prespecified primary operational cutoff based on the month-level interval from index arthroplasty to PFF. Between-group comparisons used Wilcoxon rank-sum tests, Fisher exact tests, and standardized mean differences (SMDs). P values were interpreted descriptively, and absolute percentage-point differences with 95% confidence intervals (CIs) were reported for selected binary contrasts. A 6-month cutoff was examined post hoc as a sensitivity analysis. Among 132 patients, 126 had a usable month-based interval; 23 (18.3%) had early PFF and 103 (81.7%) had late PFF. Low-energy injury was recorded in 23/23 (100.0%) early PFFs and 86/102 (84.3%) late PFFs, corresponding to an absolute difference of 15.7 percentage points (95% CI, 0.2-24.0). Vancouver B2/B3 fractures occurred in 8/23 (34.8%) versus 22/102 (21.6%) patients (absolute difference, 13.2 percentage points; 95% CI, -5.1-34.7). Surgery was performed in 21/23 (91.3%) versus 88/103 (85.4%), and ORIF was the most frequent treatment in both groups. At the 6-month cutoff, multiple fracture categories and treatment strategies remained represented in both timing groups. In this cohort, a 3-month operational grouping suggested a difference in recorded injury context, while both timing groups included multiple fracture morphologies, bone-stock categories, and treatment strategies. Timing may provide useful contextual information at presentation but should be interpreted together with Vancouver classification, implant stability, bone stock, and patient condition. These observations require validation in larger cohorts with finer timing resolution.

PMID 43041422
阅读全文 →
PubMedRadiology2026-11-17

Endovascular Treatment versus Medical Management for Acute Anterior Circulation Large Vessel Occlusion from 24 to 96 Hours.

Yi Tingyu T, Hong Lan L, Lin Xiaohui X, Li Caixia C et al.

Background The role of endovascular treatment (EVT) in acute ischemic stroke (AIS) from 24 to 96 hours after symptom onset remains uncertain. Purpose To evaluate the functional and safety outcomes of EVT versus best medical management (BMM) in patients with AIS due to large vessel occlusion (LVO) presenting greater than 24 hours to 96 hours (hereafter "24-96 hours") after symptom onset. Materials and Methods Prospectively maintained stroke registries from eight stroke centers in China (September 2020-January 2025) were analyzed in this retrospective cohort study. Patients with intracranial internal carotid artery or M1 or M2 middle cerebral artery occlusion, National Institutes of Health Stroke Scale score of 6 or higher, and Alberta Stroke Program Early CT Score of 3 or higher who presented 24-96 hours after onset were included, grouped by treatment (EVT vs BMM alone), and followed for 90 days. The primary outcome was functional independence (modified Rankin Scale score of 0-2) at 90 days. Secondary safety outcomes included symptomatic intracranial hemorrhage and 90-day mortality. Outcomes were compared using multivariable logistic regression and inverse probability of treatment weighting (IPTW), adjusted for demographic and clinical variables. Results Among 308 patients (mean age, 67 years ± 12 [SD]; 202 men), 205 underwent EVT and 103 received BMM. Functional independence at 90 days was more frequent with EVT than BMM (50.7% [104 of 205] vs 28.2% [29 of 103]; P < .001). After multivariable adjustment, the odds ratio (OR) for functional independence with EVT compared with BMM was 3.8 (95% CI: 2.1, 6.8; P < .001); after IPTW adjustment, the OR was 4.4 (95% CI: 2.4, 8.1; P < .001). After multivariable adjustment, the incidence of symptomatic intracranial hemorrhage (5.9% vs 2.9%; OR, 2.2 [95% CI: 0.6, 8.2]; P = .26) and 90-day mortality (11.2% vs 13.6%; OR, 0.6 [95% CI: 0.3, 1.4]; P = .22) did not differ between the EVT and BMM groups. Conclusion Among Chinese patients with AIS due to LVO presenting 24-96 hours after symptom onset, EVT was associated with improved functional outcomes, without clear increases in mortality or symptomatic intracranial hemorrhage. © The Author(s) 2026. Published by the Radiological Society of North America under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Russell in this issue.

PMID 43043181
阅读全文 →
PubMedFrontiers in bioinformatics2026-11-17

Benchmarking in silico predictors of deep intronic variant pathogenicity on a patient-derived cohort of inherited retinal dystrophy genes.

Shitik Ekaterina E, Zolotikov Ustin U, Mehrotra Sudeep S, Weener Marianna M

Deep intronic variants (DIVs) are an increasingly recognized cause of inherited retinal dystrophy (IRD), accounting for a substantial fraction of cases that remain unsolved after exon-focused sequencing. Dozens of in silico tools predict variant pathogenicity or splicing impact, but they have rarely been benchmarked on patient-derived DIVs, and the most recent generation of predictors, including AlphaGenome and the phylogeny-aware genomic language model GPN-Star, has never been evaluated in this setting. We assembled a cohort of 103 patient-derived candidate DIVs across 26 IRD genes (native GRCh38) and 103 benign intronic gnomAD variants (allele frequency > 0.01, all classified as benign/likely-benign in ClinVar). Ground truth was defined in two ways: 10 experimentally confirmed pathogenic DIVs and an expanded set of 36 positives obtained by adding allele-verified ClinVar pathogenic/likely-pathogenic variants. We scored all variants with seven tools spanning three methodological classes: splice-aware deep learning (SpliceAI, Pangolin, AlphaGenome, and OpenSpliceAI), general deleteriousness (CADD), and evolutionary constraint (GERP and GPN-Star). We computed AUROC, auPRC, and optimal thresholds, with a gnomAD-wide false-positive screen and a distance-matched sensitivity benchmark as robustness checks. Splice-aware deep-learning tools clearly outperformed all others: SpliceAI (AUROC 0.917), Pangolin (0.916), and AlphaGenome (0.902) were statistically indistinguishable, whereas OpenSpliceAI underperformed (0.842), and the constraint-based predictors GPN-Star (0.554) and GERP (0.559) performed near chance. The optimal SpliceAI threshold for DIVs was 0.06 three-fold lower than the standard recommendation of 0.2, which detected only 24 of 35 scorable positives; a formal test found no significant score-by-distance interaction; therefore, we recommend the pooled threshold, with distance-stratified estimates reported as exploratory. A screen of 4,787 common intronic gnomAD variants showed the relaxed threshold kept the population false-positive rate low (1.3% at 0.05 vs. 0.13% at 0.2), and a distance-matched sensitivity benchmark left all AUROCs and rankings unchanged. Three experimentally confirmed pathogenic DIVs scored ≤0.01 on SpliceAI, revealing a "deep intronic blind spot" for variants acting through non-splice-creation mechanisms. Consensus ranking of the 93 unlabeled patient DIVs nominated 26 novel, high-concordance candidates with no ClinVar entry. For patient-derived IRD DIVs, splice-aware deep-learning predictors are the tools of choice, but they require deep-intronic-specific thresholds an order of magnitude below standard defaults. General constraint-based genomic language models should not be used as proxies for splice impact. We provide an actionable threshold approach and a prioritized candidate list for functional follow-up.

PMID 43041752
阅读全文 →
PubMedEuropean endodontic journal2026-11-17

Rotary First: A Technique for Simultaneous Root Canal Negotiation and Glide Path Establishment-An In Vitro Study.

Giragosyan Hachko Garo HG, Kasabova Stela Zlatkova SZ, Filipov Ivan Atanasov IA, Armogida Niccolò Giuseppe NG et al.

This preliminary in vitro study compared active instrumentation time and instrument fracture between the rotary first technique, which combines engine-driven canal negotiation and glide path establishment, and conventional manual instrumentation. Thirty freshly extracted human maxillary molars (103 canals) with canal curvatures ≤ 30° were randomised at tooth level to the rotary first or manual group. Active instrumentation time was compared separately in palatal (P), distobuccal (DB), mesiobuccal (MB) and second mesiobuccal (MB2) canals using 2-sided Mann-Whitney U-tests with Holm-Bonferroni adjustment. Overall canal-level fracture frequencies were compared exploratorily using a 2-sided Fisher's exact test. Median active instrumentation time was lower with rotary first in every canal type. After multiplicity adjustment, the difference remained statistically significant only in MB canals (6.3 vs. 55.0 s; adjusted P = .004; rrb = 0.70). Differences in P (adjusted P = .087), DB (adjusted P = .100) and MB2 canals (adjusted P = .354) were not statistically significant. Fractures occurred in 7/53 rotary first canals (13.2%) and 2/50 manual canals (4.0%); the difference was not statistically significant (P = .162). Under the restricted anatomical conditions evaluated, rotary first reduced active instrumentation time significantly only in MB canals after adjustment. The fracture comparison was underpowered and did not account for within-tooth clustering; therefore, neither equivalent procedural safety nor the overall superiority of either protocol can be inferred.

PMID 43041045
阅读全文 →
PubMedScandinavian journal of work, environment & health2026-11-17

Occupational noise exposure and ischemic heart disease: a pooled analysis of six Nordic cohorts.

Lissåker Claudia C, Sjöström Mattias M, Pyko Andrei A, Olse Anja A et al.

Objectives This study aimed to investigate the impact of occupational noise exposure on incident ischemic heart disease (IHD), including acute myocardial infarction (AMI). We conducted a pooled analysis of six Nordic cohorts with a total of 83 103 participants with individual and area-level confounder information. Occupational codes were matched to a job-exposure matrix developed from Swedish measurements in five categories (LAeq8h): <70, 70-74, 75-79, 80-84, and ≥85 dB(A). Residential address history was used to estimate baseline 1-year average residential road traffic noise exposure. Data on incident IHD and AMI were obtained from national patient registers. We calculated hazard ratios (HR) using Cox proportional hazard models adjusted for socioeconomic and lifestyle factors. After adjustment for baseline year, sex, marital status, area-level income, education, smoking, and physical activity, exposure to ≥85 dB(A) of occupational noise was associated with an 10% and 12% increased risk of IHD, excluding angina pectoris, and AMI, respectively. For these outcomes, suggestive exposure-response trends were observed, but risks were only statistically significant for those exposed to ≥85 dB(A) as well as men exposed to ≥75 dB(A). We did not find evidence that combined exposure to both occupational noise and road traffic noise was particularly harmful. We found increased risks of IHD and AMI among those exposed to occupational noise ≥85 dB(A). Further studies should investigate whether this association is confounded by other occupational exposures.

PMID 43042760
阅读全文 →
PubMedFrontiers in neurology2026-11-17

Report-derived interictal epileptiform discharge burden is associated with 7-day antiseizure medication decisions after pediatric video electroencephalography.

Zhu Fengming F, Xu Weidong W, Gao Yun Y, Kang Shumin S et al.

To determine whether a three-level interictal epileptiform discharge (IED) burden abstracted from qualitative wording in issued pediatric video electroencephalography (VEEG) reports, rather than directly measured spike frequency, was associated with antiseizure medication (ASM) decisions within 7 days. This single-center retrospective cohort included 216 VEEG report episodes from 181 children. Two reviewers independently classified each report as showing no, low, or moderate-to-high IED burden while unaware of the standardized 7-day outcome; disagreements were adjudicated. We separately analyzed a diagnostic/initiation cohort for new ASM initiation and an established-epilepsy cohort for exploratory treatment intensification. Associations were assessed using exact and trend tests and logistic regression with patient-clustered robust standard errors. Agreement was 211/216 (97.7%); linear-weighted Cohen κ was 0.975 (patient-clustered bootstrap 95% CI 0.947-0.995). The diagnostic/initiation cohort comprised 113 reports from 112 children, with 36 new ASM initiations. Initiation rates were 13.0%, 42.9%, and 70.0% for no, low, and moderate-to-high burden, respectively (trend p < 0.001). The adjusted odds ratio per higher burden grade was 2.89 (95% CI 1.58-5.30; p < 0.001). The established-epilepsy cohort comprised 103 reports from 76 children, with 13 intensification events. Moderate-to-high burden versus none/low yielded an odds ratio of 4.73 (95% CI 1.31-17.08; p = 0.018), but complementary analyses were not statistically significant. Report-derived IED burden showed a strong graded association with new ASM initiation within 7 days. The treatment-intensification finding was exploratory. These data describe prescribing context and do not establish causality, treatment benefit, or an IED-based treatment threshold.

PMID 43041243
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多AGP-103